Did some DD on dystrophen
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206488lbl.pdf See section 14 of the eteplirsen Product Information leaflet. After 48 weeks of treatment eteplirsen only increased dystrophin levels from 0.16% of health patients to 0.44%. The median (mid-range) increase after 48 weeks was only 0.1%
Golodirsen increased mean dystrophin levels from 0.10% (SD 0.07) of normal at baseline to 1.02%(SD 1.03) of normal by Week 48 of Study 1 Part 2, with a mean change in dystrophin of 0.92% (SD 1.01) of normal levels (p<0.001); the median change from baseline was 0.88
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211970s002lbl.pdf
DMD patients (like the MDX mice) have very low levels of dystrophin protein and these Sarepta drugs increased dystrophin in piatients to about 1% of healthy subjects after 48 weeks of treatment - so very low levels to detect!
Imo: Some investors didn’t understand Mondays announcement…
Sam: once again it was a very good postcan you elaborate)
Anp does not require Dystrophen to be successful.. But after the extended study if it does show a tiny distrophen increase in the mice : it will be important to others.eg financiers.
and Pharmas and we might see a spike in the sp..
Don’t forget Sarepta only produced micro Dystrophen not the real dystrophenp
imo
We wait.
- Forums
- ASX - By Stock
- anp chart
Did some DD on...
-
- There are more pages in this discussion • 745 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.7¢ |
Change
0.002(2.35%) |
Mkt cap ! $78.43M |
Open | High | Low | Value | Volume |
8.6¢ | 8.9¢ | 8.5¢ | $53.40K | 614.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 49999 | 8.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.9¢ | 67263 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 49999 | 0.087 |
2 | 500872 | 0.085 |
2 | 262571 | 0.084 |
1 | 10000 | 0.083 |
2 | 120000 | 0.082 |
Price($) | Vol. | No. |
---|---|---|
0.089 | 67263 | 1 |
0.090 | 546175 | 2 |
0.091 | 108000 | 1 |
0.092 | 135429 | 2 |
0.093 | 175642 | 3 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online